<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:department>Life Sciences</gtr:department><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/3E049216-D7C5-40EE-929B-4B642DABE478"><gtr:id>3E049216-D7C5-40EE-929B-4B642DABE478</gtr:id><gtr:firstName>Anthony</gtr:firstName><gtr:surname>Day</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0501816"><gtr:id>3846980C-1621-4465-B969-8C801FD2BEB8</gtr:id><gtr:title>Glycosaminoglycan-protein and protein-protein interactions in inflammatory processes</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0501816</gtr:grantReference><gtr:abstractText>Important results from research will be disseminated to the public and special interest groups through press releases and by contributions to lay publications (e.g., Arthritis Today).</gtr:abstractText><gtr:technicalSummary>Glycosaminoglycans (GAGs) are polysaccharides with a central role in the regulation of protein and cell function in particular tissue microenvironments. For example, the interaction of hyaluronan - a high molecular weight GAG - with specific hyaluronan-binding proteins (hyaladherins) is critical for the formation and stability of extracellular matrix (e.g. in cartilage) and is also important in immune cell trafficking. One of the main aims of my research is to determine the structural basis and molecular regulation of hyaluronan-protein interactions. This work is focused primarily on TSG-6 - a multifunctional protein that is essential for ovulation (an inflammation-like process) and is also produced during inflammatory disease (e.g. arthritis) where it has anti-inflammatory properties and may play a role in tissue repair. Other hyaladherins under study are CD44 (a ubiquitous cell surface receptor for hyaluronan), which is involved in matrix assembly and leukocyte migration, and the extracellular matrix components aggrecan, versican and link protein that are crucial for matrix structure. In addition to hyaluronan, TSG-6 binds to sulphated GAGs (i.e. heparin, heparan sulphate, chondroitin-4-sulphate and dermatan sulphate) as well as a growing list of proteins (e.g. aggrecan, inter- -inhibitor, PTX3, TSP1) where these interactions have differential effects on its functional activities. This makes TSG-6 an ideal model system to investigate microenvironment control in inflammatory processes both at a structural and functional level.</gtr:technicalSummary><gtr:fund><gtr:end>2008-09-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>150000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/055FFFDE-24B7-4861-937D-BC741F1EECDC"><gtr:id>055FFFDE-24B7-4861-937D-BC741F1EECDC</gtr:id><gtr:title>Complement factor H in host defense and immune evasion.</gtr:title><gtr:parentPublicationTitle>Cellular and molecular life sciences : CMLS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2779340c9560dc62c5003cab48c5c692"><gtr:id>2779340c9560dc62c5003cab48c5c692</gtr:id><gtr:otherNames>Parente R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1420-682X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/52112F4B-4FE2-4AB1-A28D-3ED12085B787"><gtr:id>52112F4B-4FE2-4AB1-A28D-3ED12085B787</gtr:id><gtr:title>Hyaluronan, TSG-6, and inter-a-inhibitor in periprosthetic breast capsules: reduced levels of free hyaluronan and TSG-6 expression in contracted capsules.</gtr:title><gtr:parentPublicationTitle>Aesthetic surgery journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/73c92f074e1d15e99d93957587f74b1f"><gtr:id>73c92f074e1d15e99d93957587f74b1f</gtr:id><gtr:otherNames>Tan KT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1090-820X</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0501816</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>